查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1939192

2026年全球急性护理症候群诊断市场报告

Acute Care Syndromic Testing Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，急性护理中的综合征检测市场规模迅速扩大，预计将以 12.8% 的复合年增长率增长，从 2025 年的 45.9 亿美元增长到 2026 年的 51.7 亿美元。过去几年成长要素包括对紧急感染疾病诊断的需求、医院加护病房的扩建、感染疾病防范工作、分子诊断技术的应用以及重症监护工作流程的优化。

预计未来几年，急性症候群检测市场将快速成长，到2030年市场规模将达到83亿美元，复合年增长率（CAGR）为12.5%。预测期内的成长要素包括人工智慧赋能的综合征检测、急诊检测的扩展、抗菌药物管理计划、照护现场分子诊断系统以及对疫情防范的重视。预测期内的关键趋势包括快速多病原体检测、急诊室的分子检测、单检体多疾病检测、更快的临床决策支援以及更快的诊断结果週转时间。

感染疾病率的上升预计将推动急性护理机构中综合症检测市场的成长。由细菌、病毒、真菌和寄生虫等有害微生物引起的感染疾病可透过人际接触、动物和环境传播。人口增长、都市化、国际旅行、抗菌素抗药性和气候变迁等因素导致这些疾病的发病率上升，从而推动了对有效诊断和治疗方案的需求。急性期综合症检测透过多重分子诊断技术在识别病原体和合併感染方面发挥关键作用，从而实现精准治疗决策。例如，根据英国卫生安全执行局2024年2月发布的报告，2024年第4週的流感阳性率从前一周的14.0%上升至16.6%。流感样疾病（ILI）就诊人数也有所增加，从前一週的每10万人7.5人增加到9.8人。同时，流感相关住院人数从前一週的每10万人有5.12人上升至7.63人。因此，感染疾病的上升趋势正在推动急性症候群检测市场的扩张。

急性症候群检测市场的主要企业正利用多重即时聚合酵素链锁反应(PCR) 技术的进步来提高诊断准确性、实现病原体快速检测、简化检查室工作流程并缩短检测结果报告时间。多重即时PCR是一种先进的分子诊断方法，可在单次反应中同时检测和定量多种病原体或基因标靶，从而提高疾病诊断的效率和准确性。 2023 年 4 月，总部位于荷兰的生物技术公司 QIAGEN NV 在日本推出了 QIAstat-Dx 症候群检测解决方案。该系统配备了 SARS-CoV-2 呼吸道病原体检测板，能够从单一检体中检测 20 多种病原体。与传统 PCR 检测相比，该系统利用多重即时PCR技术，能够以最少的人力快速获得检测结果。截至 2022 年底，全球已安装超过 3500 套 QIAstat-Dx 系统，用于支持呼吸道疾病、胃肠道疾病和脑膜炎相关疾病的诊断。该系统已在 100 多个国家/地区投入使用，有助于提高全球对综合征检测的可及性。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球急性护理综合症诊断市场：吸引力评分及分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 生物技术、基因组学和精准医学
    • 人工智慧（AI）和自主人工智慧
    • 数位化、云端运算、巨量资料、网路安全
    • 工业4.0和智慧製造
    • 物联网、智慧基础设施和互联生态系统
  • 主要趋势
    • 快速多重病原体检测
    • 急诊室的分子检测
    • 单检体多病种检测
    • 加速临床决策支持
    • 缩短诊断结果等待时间

第五章 终端用户产业市场分析

  • 医院
  • 急诊室
  • 临床检查室
  • 加护病房
  • 公共卫生实验室

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球急性照护症候群诊断市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 全球急性护理症候群诊断市场规模、对比及成长率分析
  • 全球急性照护症候群诊断市场表现：规模与成长，2020-2025年
  • 全球急性照护症候群诊断市场预测：规模与成长，2025-2030年，2035年预测

第八章 全球潜在市场规模（TAM）

第九章 市场细分

  • 依疾病类型
  • 呼吸系统疾病、消化系统疾病、泌尿生殖系统疾病、热带疾病等疾病类型
  • 依检体类型
  • 血液、尿液、体液、粪便、拭子和其他检体
  • 按目标
  • 细菌、病毒、真菌、寄生虫
  • 最终用户
  • 医院、临床检查室、研究和学术机构以及其他最终用户
  • 按类型细分：呼吸系统疾病
  • 流感、呼吸道融合细胞病毒（RSV）、新冠病毒、结核病和其他呼吸道疾病
  • 按类型细分：胃肠道疾病
  • 困难梭状芽孢桿菌传染病、诺罗病毒、轮状病毒、沙门氏菌和其他胃肠道疾病
  • 依类型细分：泌尿生殖系统疾病
  • 尿道感染（UTI）、性行为感染感染（STI）、阴道感染疾病和其他泌尿生殖系统疾病
  • 按类型细分：热带疾病
  • 疟疾、登革热、基孔肯雅热、兹卡病毒和其他热带疾病
  • 按类型细分：其他疾病类型
  • 脑膜炎、败血症和其他新兴感染疾病

第十章 区域与国家分析

  • 全球急性照护症候群诊断市场：依地区、绩效及预测划分，2020-2025年、2025-2030年预测、2035年预测
  • 全球急性照护症候群诊断市场：国家、绩效及预测，2020-2025年、2025-2030年预测、2035年预测

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第三十六章：竞争格局与公司概况

  • 急性护理症候群诊断市场：竞争格局与市场份额，2024 年
  • 急性照护症候群诊断市场：公司估值矩阵
  • 急性护理综合症诊断市场：公司简介
    • Siemens Healthineers AG
    • F. Hoffmann-La Roche Ltd
    • Thermo Fisher Scientific Inc.
    • Danaher Corporation
    • Becton, Dickinson and Company

第37章：其他领先和创新企业

  • Seegene Inc., bioMerieux SA, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN NV, Werfen, DiaSorin SpA, Quidel Corporation, Luminex Corporation, Biocartis NV, Microbiologics Inc., QuantuMDx Group Ltd., Curetis GmbH by OpGen Inc., Genetic Signatures Ltd., Applied BioCode Inc.

第38章 全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年急性照护症候群诊断市场：提供新机会的国家
  • 2030年急性照护症候群诊断市场：提供新机会的细分市场
  • 2030年急性照护症候群诊断市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME4MACST01_G26Q1

Acute care syndromic testing is a rapid molecular diagnostic approach that detects multiple pathogens simultaneously from a single patient sample. Primarily used in emergency and critical care settings, it enables quicker diagnosis of infectious diseases, leading to faster treatment decisions, improved patient outcomes, and reduced hospital stays.

The main disease types in the acute care syndromic testing market include respiratory diseases, gastrointestinal diseases, genitourinary diseases, tropical diseases, and others. Respiratory diseases affect the lungs, airways, and respiratory tract, causing symptoms such as coughing, shortness of breath, and fever. Various sample types used for testing include blood, urine, biofluids, stool, swabs, and more. The tests target bacteria, viruses, fungi, and parasites and are utilized in hospitals, clinical and diagnostic laboratories, research and academic institutions, and other healthcare settings.

Tariffs have increased costs of reagents, cartridges, and molecular testing platforms in the acute care syndromic testing market. Respiratory and gastrointestinal panels are most affected, particularly in regions reliant on imported diagnostics. However, tariffs have accelerated local manufacturing and innovation in compact, cost-efficient testing systems.

The acute care syndromic testing market research report is one of a series of new reports from The Business Research Company that provides acute care syndromic testing market statistics, including acute care syndromic testing industry global market size, regional shares, competitors with a acute care syndromic testing market share, detailed acute care syndromic testing market segments, market trends and opportunities, and any further data you may need to thrive in the acute care syndromic testing industry. This acute care syndromic testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The acute care syndromic testing market size has grown rapidly in recent years. It will grow from $4.59 billion in 2025 to $5.17 billion in 2026 at a compound annual growth rate (CAGR) of 12.8%. The growth in the historic period can be attributed to emergency infection diagnosis demand, hospital ICU expansion, outbreak preparedness initiatives, molecular diagnostic adoption, critical care workflow optimization.

The acute care syndromic testing market size is expected to see rapid growth in the next few years. It will grow to $8.3 billion in 2030 at a compound annual growth rate (CAGR) of 12.5%. The growth in the forecast period can be attributed to AI-enabled syndromic panels, expansion of emergency testing, antimicrobial stewardship programs, point-of-care molecular systems, pandemic preparedness focus. Major trends in the forecast period include rapid multiplex pathogen detection, emergency department molecular testing, single-sample multi-disease panels, faster clinical decision support, reduced diagnostic turnaround time.

The increasing prevalence of infectious diseases is expected to drive the growth of the acute care syndromic testing market. Infectious diseases, caused by harmful microorganisms such as bacteria, viruses, fungi, or parasites, can spread through human contact, animals, or the environment. Factors such as population growth, urbanization, global travel, antimicrobial resistance, and climate change are contributing to the rising incidence of these diseases, increasing the demand for effective diagnostic and treatment solutions. Acute care syndromic testing plays a crucial role in identifying pathogens and co-infections through multiplex molecular diagnostics, allowing for targeted treatment decisions. For example, in February 2024, the UK Health Security Agency reported that in week 4 of 2024, the influenza positivity rate rose to 16.6%, up from 14.0% the previous week. Influenza-like illness (ILI) consultations also increased, reaching 9.8 per 100,000 people compared to 7.5 per 100,000 in the prior week, while influenza hospitalizations climbed from 5.12 to 7.63 per 100,000. Consequently, the growing incidence of infectious diseases is fueling the expansion of the acute care syndromic testing market.

Leading companies in the acute care syndromic testing market are leveraging advancements in multiplex real-time polymerase chain reaction (PCR) technology to enhance diagnostic accuracy, enable rapid pathogen detection, streamline laboratory workflows, and reduce turnaround time. Multiplex real-time PCR is an advanced molecular diagnostic method that simultaneously detects and quantifies multiple pathogens or genetic targets in a single reaction, improving efficiency and accuracy in disease diagnosis. In April 2023, QIAGEN N.V., a Netherlands-based biotechnology company, launched the QIAstat-Dx syndromic testing solution in Japan. This system features a SARS-CoV-2 respiratory panel capable of detecting over 20 pathogens from a single sample. Using multiplex real-time PCR technology, it provides rapid results with minimal labor compared to traditional PCR assays. By the end of 2022, over 3,500 QIAstat-Dx systems had been installed worldwide, aiding in the diagnosis of respiratory, gastrointestinal, and meningitis-related conditions. Available in more than 100 countries, this system is improving global access to syndromic testing.

In May 2023, Applied BioCode, a US-based biotechnology company, partnered with Medline Industries to expand the distribution of the BioCode MDx-3000 System. This collaboration aims to enhance access to diagnostic testing for hospitals and reference laboratories across the U.S. Medline Industries LP, a US-based healthcare company specializing in medical supplies and healthcare services, will support the distribution of Applied BioCode's multiplex diagnostic solutions, further advancing syndromic testing capabilities.

Major companies operating in the acute care syndromic testing market are Siemens Healthineers AG, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Danaher Corporation, Becton Dickinson and Company, Seegene Inc., bioMerieux SA, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Werfen, DiaSorin S.p.A., Quidel Corporation, Luminex Corporation, Biocartis NV, Microbiologics Inc., QuantuMDx Group Ltd., Curetis GmbH by OpGen Inc., Genetic Signatures Ltd., Applied BioCode Inc.

North America was the largest region in the acute care syndromic testing market in 2025. The regions covered in the acute care syndromic testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the acute care syndromic testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The acute care syndromic testing market consists of revenues earned by entities by providing services such as comprehensive pathogen detection, rapid turnaround time, and support for antimicrobial stewardship. The market value includes the value of related goods sold by the service provider or included within the service offering. The acute care syndromic testing market also includes sales of blood collection tubes, or urine containers, PCR and RT-PCR machines, and reader devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Acute Care Syndromic Testing Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses acute care syndromic testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for acute care syndromic testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The acute care syndromic testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Disease Type: Respiratory Diseases; Gastrointestinal Diseases; Genitourinary Diseases; Tropical Diseases; Other Disease Types
  • 2) By Sample Type: Blood; Urine; Biofluids; Stool; Swabs; Other Sample Types
  • 3) By Target: Bacteria; Viruses; Fungi; Parasites
  • 4) By End User: Hospitals; Clinical And Diagnostic Laboratories; Research And Academic Institutions; Other End Users
  • Subsegments:
  • 1) By Respiratory Diseases: Influenza; Respiratory Syncytial Virus (RSV); COVID-19; Tuberculosis; Other Respiratory Diseases
  • 2) By Gastrointestinal Diseases: Clostridium Difficile Infection; Norovirus; Rotavirus; Salmonella; Other Gastrointestinal Diseases
  • 3) By Genitourinary Diseases: Urinary Tract Infections (UTIs); Sexually Transmitted Infections (STIs); Vaginal Infections; Other Genitourinary Diseases
  • 4) By Tropical Diseases: Malaria; Dengue; Chikungunya; Zika Virus; Other Tropical Diseases
  • 5) By Other Disease Types: Meningitis; Sepsis; Other Emerging Infectious Diseases
  • Companies Mentioned: Siemens Healthineers AG; F. Hoffmann-La Roche Ltd; Thermo Fisher Scientific Inc.; Danaher Corporation; Becton Dickinson and Company; Seegene Inc.; bioMerieux SA; Sysmex Corporation; Bio-Rad Laboratories Inc.; QIAGEN N.V.; Werfen; DiaSorin S.p.A.; Quidel Corporation; Luminex Corporation; Biocartis NV; Microbiologics Inc.; QuantuMDx Group Ltd.; Curetis GmbH by OpGen Inc.; Genetic Signatures Ltd.; Applied BioCode Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Acute Care Syndromic Testing Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Acute Care Syndromic Testing Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Acute Care Syndromic Testing Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Acute Care Syndromic Testing Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Artificial Intelligence & Autonomous Intelligence
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Industry 4.0 & Intelligent Manufacturing
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Rapid Multiplex Pathogen Detection
    • 4.2.2 Emergency Department Molecular Testing
    • 4.2.3 Single-Sample Multi-Disease Panels
    • 4.2.4 Faster Clinical Decision Support
    • 4.2.5 Reduced Diagnostic Turnaround Time

5. Acute Care Syndromic Testing Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Emergency Care Units
  • 5.3 Clinical Diagnostic Laboratories
  • 5.4 Intensive Care Units
  • 5.5 Public Health Laboratories

6. Acute Care Syndromic Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Acute Care Syndromic Testing Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Acute Care Syndromic Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Acute Care Syndromic Testing Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Acute Care Syndromic Testing Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Acute Care Syndromic Testing Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Acute Care Syndromic Testing Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Acute Care Syndromic Testing Market Segmentation

  • 9.1. Global Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Respiratory Diseases, Gastrointestinal Diseases, Genitourinary Diseases, Tropical Diseases, Other Disease Types
  • 9.2. Global Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Blood, Urine, Biofluids, Stool, Swabs, Other Sample Types
  • 9.3. Global Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Bacteria, Viruses, Fungi, Parasites
  • 9.4. Global Acute Care Syndromic Testing Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Clinical And Diagnostic Laboratories, Research And Academic Institutions, Other End Users
  • 9.5. Global Acute Care Syndromic Testing Market, Sub-Segmentation Of Respiratory Diseases, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Influenza, Respiratory Syncytial Virus (RSV), COVID-19, Tuberculosis, Other Respiratory Diseases
  • 9.6. Global Acute Care Syndromic Testing Market, Sub-Segmentation Of Gastrointestinal Diseases, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Clostridium Difficile Infection, Norovirus, Rotavirus, Salmonella, Other Gastrointestinal Diseases
  • 9.7. Global Acute Care Syndromic Testing Market, Sub-Segmentation Of Genitourinary Diseases, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Urinary Tract Infections (UTIs), Sexually Transmitted Infections (STIs), Vaginal Infections, Other Genitourinary Diseases
  • 9.8. Global Acute Care Syndromic Testing Market, Sub-Segmentation Of Tropical Diseases, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Malaria, Dengue, Chikungunya, Zika Virus, Other Tropical Diseases
  • 9.9. Global Acute Care Syndromic Testing Market, Sub-Segmentation Of Other Disease Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Meningitis, Sepsis, Other Emerging Infectious Diseases

10. Acute Care Syndromic Testing Market Regional And Country Analysis

  • 10.1. Global Acute Care Syndromic Testing Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Acute Care Syndromic Testing Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Acute Care Syndromic Testing Market

  • 11.1. Asia-Pacific Acute Care Syndromic Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Acute Care Syndromic Testing Market, Segmentation By Disease Type, Segmentation By Sample Type, Segmentation By Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Acute Care Syndromic Testing Market

  • 12.1. China Acute Care Syndromic Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Acute Care Syndromic Testing Market, Segmentation By Disease Type, Segmentation By Sample Type, Segmentation By Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Acute Care Syndromic Testing Market

  • 13.1. India Acute Care Syndromic Testing Market, Segmentation By Disease Type, Segmentation By Sample Type, Segmentation By Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Acute Care Syndromic Testing Market

  • 14.1. Japan Acute Care Syndromic Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Acute Care Syndromic Testing Market, Segmentation By Disease Type, Segmentation By Sample Type, Segmentation By Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Acute Care Syndromic Testing Market

  • 15.1. Australia Acute Care Syndromic Testing Market, Segmentation By Disease Type, Segmentation By Sample Type, Segmentation By Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Acute Care Syndromic Testing Market

  • 16.1. Indonesia Acute Care Syndromic Testing Market, Segmentation By Disease Type, Segmentation By Sample Type, Segmentation By Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Acute Care Syndromic Testing Market

  • 17.1. South Korea Acute Care Syndromic Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Acute Care Syndromic Testing Market, Segmentation By Disease Type, Segmentation By Sample Type, Segmentation By Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Acute Care Syndromic Testing Market

  • 18.1. Taiwan Acute Care Syndromic Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Acute Care Syndromic Testing Market, Segmentation By Disease Type, Segmentation By Sample Type, Segmentation By Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Acute Care Syndromic Testing Market

  • 19.1. South East Asia Acute Care Syndromic Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Acute Care Syndromic Testing Market, Segmentation By Disease Type, Segmentation By Sample Type, Segmentation By Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Acute Care Syndromic Testing Market

  • 20.1. Western Europe Acute Care Syndromic Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Acute Care Syndromic Testing Market, Segmentation By Disease Type, Segmentation By Sample Type, Segmentation By Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Acute Care Syndromic Testing Market

  • 21.1. UK Acute Care Syndromic Testing Market, Segmentation By Disease Type, Segmentation By Sample Type, Segmentation By Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Acute Care Syndromic Testing Market

  • 22.1. Germany Acute Care Syndromic Testing Market, Segmentation By Disease Type, Segmentation By Sample Type, Segmentation By Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Acute Care Syndromic Testing Market

  • 23.1. France Acute Care Syndromic Testing Market, Segmentation By Disease Type, Segmentation By Sample Type, Segmentation By Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Acute Care Syndromic Testing Market

  • 24.1. Italy Acute Care Syndromic Testing Market, Segmentation By Disease Type, Segmentation By Sample Type, Segmentation By Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Acute Care Syndromic Testing Market

  • 25.1. Spain Acute Care Syndromic Testing Market, Segmentation By Disease Type, Segmentation By Sample Type, Segmentation By Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Acute Care Syndromic Testing Market

  • 26.1. Eastern Europe Acute Care Syndromic Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Acute Care Syndromic Testing Market, Segmentation By Disease Type, Segmentation By Sample Type, Segmentation By Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Acute Care Syndromic Testing Market

  • 27.1. Russia Acute Care Syndromic Testing Market, Segmentation By Disease Type, Segmentation By Sample Type, Segmentation By Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Acute Care Syndromic Testing Market

  • 28.1. North America Acute Care Syndromic Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Acute Care Syndromic Testing Market, Segmentation By Disease Type, Segmentation By Sample Type, Segmentation By Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Acute Care Syndromic Testing Market

  • 29.1. USA Acute Care Syndromic Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Acute Care Syndromic Testing Market, Segmentation By Disease Type, Segmentation By Sample Type, Segmentation By Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Acute Care Syndromic Testing Market

  • 30.1. Canada Acute Care Syndromic Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Acute Care Syndromic Testing Market, Segmentation By Disease Type, Segmentation By Sample Type, Segmentation By Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Acute Care Syndromic Testing Market

  • 31.1. South America Acute Care Syndromic Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Acute Care Syndromic Testing Market, Segmentation By Disease Type, Segmentation By Sample Type, Segmentation By Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Acute Care Syndromic Testing Market

  • 32.1. Brazil Acute Care Syndromic Testing Market, Segmentation By Disease Type, Segmentation By Sample Type, Segmentation By Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Acute Care Syndromic Testing Market

  • 33.1. Middle East Acute Care Syndromic Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Acute Care Syndromic Testing Market, Segmentation By Disease Type, Segmentation By Sample Type, Segmentation By Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Acute Care Syndromic Testing Market

  • 34.1. Africa Acute Care Syndromic Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Acute Care Syndromic Testing Market, Segmentation By Disease Type, Segmentation By Sample Type, Segmentation By Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Acute Care Syndromic Testing Market Regulatory and Investment Landscape

36. Acute Care Syndromic Testing Market Competitive Landscape And Company Profiles

  • 36.1. Acute Care Syndromic Testing Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Acute Care Syndromic Testing Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Acute Care Syndromic Testing Market Company Profiles
    • 36.3.1. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Becton, Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

37. Acute Care Syndromic Testing Market Other Major And Innovative Companies

  • Seegene Inc., bioMerieux SA, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Werfen, DiaSorin S.p.A., Quidel Corporation, Luminex Corporation, Biocartis NV, Microbiologics Inc., QuantuMDx Group Ltd., Curetis GmbH by OpGen Inc., Genetic Signatures Ltd., Applied BioCode Inc.

38. Global Acute Care Syndromic Testing Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Acute Care Syndromic Testing Market

40. Acute Care Syndromic Testing Market High Potential Countries, Segments and Strategies

  • 40.1 Acute Care Syndromic Testing Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Acute Care Syndromic Testing Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Acute Care Syndromic Testing Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer